אולנזפין טבע ® 15 מ"ג

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

OLANZAPINE 15 MG

MAH:

SALOMON,LEVIN & ELSTEIN LTD

ATC_code:

N05AH03

pharmaceutical_form:

FILM COATED TABLETS

administration_route:

PER OS

manufactured_by:

TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY

therapeutic_group:

OLANZAPINE

therapeutic_indication:

Acute and maintenance treatment of schizophrenia. Olanzapine Teva® is indicated for the management of the manifestations of psychotic disorders. Olanzapine Teva® is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.Prevention of recurrence in Bipolar Disorder: In patients whose manic episode has responded to olanzapine treatment Olanzapine Teva® is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder. The combination of Olanzapine Teva® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

authorization_date:

2011-04-01